NUCLEAR MEDICINE AND BIOLOGY
Scope & Guideline
Connecting breakthroughs in nuclear medicine with biological insights.
Introduction
Aims and Scopes
- Development of Radiopharmaceuticals:
The journal emphasizes research on the synthesis, optimization, and characterization of radiopharmaceuticals, including novel agents for imaging and therapy. - Molecular Imaging Techniques:
There is a strong focus on the advancement of imaging modalities such as PET, SPECT, and hybrid imaging techniques, which are critical for diagnosing and monitoring diseases. - Theranostics:
The integration of diagnostic and therapeutic applications, particularly in the context of targeted radiotherapy and personalized medicine, is a core area of exploration. - Radiochemistry Innovations:
Research that explores new radiochemical methodologies, including novel labeling techniques and automation of synthesis processes, is a significant aspect of the journal. - Preclinical and Clinical Applications:
The journal publishes studies that bridge the gap between laboratory research and clinical applications, showcasing the translational potential of nuclear medicine. - Biomarker Development:
The identification and evaluation of biomarkers for various diseases, particularly cancer, through imaging and radiolabeled compounds are highlighted.
Trending and Emerging
- Targeted Alpha Therapy (TAT):
There is a growing interest in targeted alpha therapy, reflecting advancements in the understanding of radiobiology and the therapeutic potential of alpha-emitting isotopes for cancer treatment. - Artificial Intelligence in Imaging:
The integration of artificial intelligence and machine learning techniques in imaging analysis and radiopharmaceutical development is rapidly emerging as a key focus area. - Bioconjugation Techniques:
Research on bioconjugation strategies for enhancing the delivery and efficacy of radiopharmaceuticals is trending, particularly in the context of antibody-drug conjugates. - Immuno-PET Imaging:
The application of PET imaging with immunoconjugates for monitoring immune responses and cancer therapies is increasingly prominent, reflecting the growing field of immuno-oncology. - Nanoparticle-based Imaging and Therapy:
The use of nanoparticles for targeted imaging and therapy is gaining traction, with studies focusing on their unique properties for enhancing drug delivery and imaging sensitivity. - Radioligand Development for CNS Disorders:
There is an emerging trend in developing radioligands specifically for imaging central nervous system disorders, reflecting the need for better diagnostic tools in neurology.
Declining or Waning
- Traditional Radiopharmaceuticals:
There is a noticeable decline in studies focused on traditional radiopharmaceuticals, as newer, more targeted agents and approaches gain popularity. - Non-targeted Imaging Approaches:
Research on non-targeted imaging methods appears to be waning, as the field increasingly emphasizes precision medicine and targeted imaging agents. - Basic Radiochemistry:
Papers focusing exclusively on basic radiochemistry without applications in imaging or therapy are becoming less frequent, reflecting a trend towards more applied research. - Conventional SPECT Imaging:
The prevalence of conventional SPECT imaging studies has decreased, possibly due to the increasing adoption of PET and hybrid imaging techniques that offer higher sensitivity and resolution. - Invasive Procedures in Imaging:
Research involving invasive imaging procedures has diminished as the focus shifts towards less invasive and more patient-friendly imaging technologies.
Similar Journals
Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique
Unveiling the Science Behind Nuclear Medicine.Medicine Nucleaire-Imagerie Fonctionnelle et Metabolique is a prominent journal published by Elsevier France-Editions Scientifiques Medicales Elsevier, dedicated to the specialized fields of nuclear medicine and functional imaging. With an ISSN of 0928-1258 and an E-ISSN of 1878-6820, this esteemed publication has been a crucial platform for the dissemination of research and developments in the discipline since its inception in 1993. Covering a wide array of topics within biophysics, radiological and ultrasound technology, and radiology, the journal currently holds a Q4 category ranking in these fields, reflecting its significance within the academic community. Although there are currently no open access options available for readers, the journal caters to a niche audience of researchers, professionals, and students who seek to enhance their understanding of metabolic imaging and its applications. The 2023 Scopus ranks indicate its position as an emerging source of knowledge in a competitive landscape, making it an important resource for the latest studies and innovations in nuclear medicine.
Translational Cancer Research
Advancing oncology through groundbreaking research.Translational Cancer Research, published by AME Publishing Company in Hong Kong, is a pivotal journal aimed at fostering the advancement of oncology-related knowledge through the dissemination of high-quality research findings. With its ISSN 2218-676X and E-ISSN 2219-6803, this journal serves as a vital resource for researchers, professionals, and students in the fields of Cancer Research, Oncology, and Radiology, Nuclear Medicine, and Imaging. Established in 2012, the journal covers the latest breakthroughs and cross-disciplinary approaches that drive innovation in cancer treatment and diagnostics. Although currently classified in the Q4 Quartile for Cancer Research and Q3 for both Oncology and Radiology, Translational Cancer Research continuously works toward improving its academic influence and impact, evidenced by its ongoing research contributions. The journal emphasizes open access, making crucial research available to a global audience. We invite scholars and industry professionals to engage with the latest findings and discussions within these critical areas of medical science.
SEMINARS IN NUCLEAR MEDICINE
Bridging research and clinical excellence in nuclear medicine.Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Connecting Researchers to Shape the Future of Imaging Science.The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.
World Journal of Nuclear Medicine
Pioneering Knowledge in Nuclear Medicine's Evolving LandscapeWorld Journal of Nuclear Medicine, published by THIEME MEDICAL PUBL INC, is a premier peer-reviewed journal dedicated to advancing the field of nuclear medicine. With an Open Access model established since 2011, this journal ensures that high-quality research is accessible to a wide audience, fostering knowledge sharing and collaboration among researchers, clinicians, and students alike. The journal aims to publish innovative studies, reviews, and clinical trials that contribute significantly to both the theoretical and practical aspects of nuclear medicine, enhancing diagnostic and therapeutic techniques within this critical area of healthcare. As the journal continues to grow in visibility and impact, it remains an essential resource for those seeking to stay at the forefront of advancements in nuclear medicine.
Imaging
Pioneering Research in Radiology and BeyondImaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.
Current Radiopharmaceuticals
Illuminating the future of nuclear medicine and imaging.Current Radiopharmaceuticals, published by Bentham Science Publishers Ltd, is an esteemed journal dedicated to advancing the field of radiopharmaceuticals. With an ISSN of 1874-4710 and an E-ISSN of 1874-4729, this journal has been a significant platform for researchers since its inception in 2009, and will continue to contribute to the literature until at least 2024. Current Radiopharmaceuticals is recognized for its impactful contributions, holding a record of Q3 in Pharmacology and Q2 in Radiology, Nuclear Medicine, and Imaging as of 2023, illustrating its vital role in these domains. The journal aims to provide a comprehensive overview of the latest techniques, applications, and innovations within the field of radiopharmaceutical science, catering to a diverse audience of researchers, professionals, and students. Despite its significant contributions, the journal remains committed to enriching the academic community with high-quality, peer-reviewed articles that can be accessed worldwide, reflecting a dedication to open dialogue and knowledge dissemination in radiopharmaceutical research.
Clinical Imaging
Pioneering Discoveries in Radiology and Nuclear MedicineClinical Imaging, published by Elsevier Science Inc, is a renowned journal dedicated to the field of radiology, nuclear medicine, and imaging. With an ISSN of 0899-7071 and an E-ISSN of 1873-4499, this esteemed publication has established its significance in advancing imaging science since its inception in 1989 and continues to make impactful contributions to the discipline through 2024. The journal holds a prestigious Q2 ranking in the category of Radiology, Nuclear Medicine, and Imaging, reflecting its critical role in bridging research and clinical practice. Currently ranked #113 out of 333 by Scopus, with a notable 66th percentile, it offers a platform for disseminating high-quality research, reviews, and case studies that inspire innovation and enhance imaging techniques. Although it primarily functions as a subscription-based journal, it remains dedicated to accessibility and the dissemination of pivotal findings that inform both academia and clinical settings. Clinical Imaging is essential for researchers, professionals, and students alike, offering insights that shape the future of diagnostic imaging.
Molecular Imaging
Unveiling the Secrets of Molecular Structures.Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.
BMC MEDICAL IMAGING
Shaping Tomorrow's Imaging Solutions for Better Patient Care.BMC Medical Imaging is a premier open-access journal dedicated to advancing the field of radiology, nuclear medicine, and imaging technologies. Published by BMC in the United Kingdom, this journal serves as a vital resource for researchers, clinicians, and students, fostering a collaborative environment for sharing innovative findings and methodologies in medical imaging. With a commendable impact factor and an impressive Scopus ranking within the top 35% of its category, BMC Medical Imaging provides a platform for high-quality research to be disseminated widely and freely since its inception in 2001. The journal aims to cover a diverse array of topics, from advanced imaging techniques to their clinical applications, enhancing the understanding and effectiveness of diagnostic practices. By contributing to the body of knowledge and facilitating open access to research, BMC Medical Imaging plays a pivotal role in shaping the future of medical imaging and improving patient care.